Skip to main content
. 2022 May 10:10.1111/jgs.17837. Online ahead of print. doi: 10.1111/jgs.17837

FIGURE 1.

FIGURE 1

Study flowchart. *Among COV‐Yes subjects, 20 out of 74 in the Main cohort and 7 out of 93 in the Confirmatory cohort had SARS‐CoV‐2 infection a few days after the 2nd vaccine dose (February–March 2021). All other subjects had SARS‐CoV‐2 infection prior to the 1st vaccine dose.